New cymbalta contraindication

Duloxetine has been associated with an increase in blood pressure and cases of hypertensive crisis have been reported, especially in patients with pre-existing hypertension.

Therefore, Cymbalta (duloxetine hydrochloride) is now contraindicated in patients with uncontrolled hypertension. For patients who experience a sustained increase in blood pressure while receiving duloxetine, either a dose reduction or gradual discontinuation should be considered. In patients with known hypertension and/or other cardiac disease, blood pressure monitoring is recommended, especially during the first month of treatment.

Further information: Lilly 01256 315000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more